Agilent Technologies, Inc.

“Agilent is a structurally sound analytical instruments business with durable installed-base economics in Western regulated markets, but it is not an exceptional compounder. The moat is actively eroding in China (structural government-directed substitution), management has demonstrated costly optimism bias at peak cycle (NASD expansion, RESOLUTION acquisition), and the stock at $114.52 with a 17.4x forward P/E already prices in an earnings recovery — leaving no margin of safety. The 10-year base case returns approximately 7% CAGR, insufficient to compensate for structural China headwinds and above-average beta. TRACK for an entry in the high-$80s where the risk/reward becomes genuinely compelling.”